ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

DCT Counselors Ponder Coordination, New Opportunities

December 12, 1975

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

Reports On AACR Scientific Sessions

May 21, 1976

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984